Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine Abuse

NCT: NCT04264741 · COMPLETED

NCT IDNCT04264741
StatusCOMPLETED
Start Date2020-02-01
Completion2022-12-31
SponsorShanghai Mental Health Center (OTHER)
First posted
Last updated

Brief Summary

Repetitive transcranial magnetic stimulation (rTMS) has been used to treat opioid and methamphetamine addiction in previous studies, while no evidence was proved for patients methadone maintenance therapy with methamphetamine abuse. The aim of this study is to evaluating the effectiveness and safety of rTMS treatment for methamphetamine abuse in patients with methadone maintenance therapy.

Frequently Asked Questions

What is Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine Abuse?

Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine Abuse is a clinical trial registered under NCT04264741. Current status: COMPLETED.

What is the status of NCT04264741?

The current status of NCT04264741 (Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine Abuse) is: COMPLETED.

When did Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine Abuse start?

Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine Abuse started on 2020-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑